Dominik Hoelper

Dominik Hoelper is an experienced regulatory and medical writer currently working at Bioscript Group since June 2023. Prior to this role, Dominik served as a Medical Writer 1 at IQVIA from March 2021 to June 2023, where responsibilities included leading the preparation of regulatory documents and providing writing support for clinical research manuscripts. Dominik's academic journey includes a postdoctoral researcher position at The University of Edinburgh, focusing on CRISPR/dCas9 technology, and a doctoral research role at the University of Wisconsin-Madison, investigating chromatin-associated proteins in cancer. Dominik holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison, an M.Sc. in Life and Medical Sciences, and a B.Sc. in Molecular Biomedicine, all from the University of Bonn.